June 2022 in “Frontiers in Medicine” This review discusses acupuncture and moxibustion for alopecia and reports evidence suggesting their efficacy for various types of hair loss, but notes barriers like cost and aversion to needles.
June 2021 in “Health and Society” In this study, lifestyle changes, particularly weight loss, were reported to improve symptoms and prognosis of Polycystic Ovary Syndrome, especially in patients who are overweight or obese.
3 citations
,
April 2022 in “Farmacia” This review examines studies from 2019-2022 on dietary treatments for skin diseases, highlighting various foods and supplements that may aid in managing conditions like acne, psoriasis, and alopecia areata.
3 citations
,
November 2020 in “Phyton-international Journal of Experimental Botany” This review discusses the potential therapeutic applications of wedelolactone, a compound in Eclipta prostrata, for various chronic human diseases and reports no new clinical results.
February 2026 in “Humanities & Social Sciences Reviews” This study reviewed existing literature on mesotherapy as a treatment for androgenetic alopecia, finding that it may improve hair density and thickness with generally mild side effects, but emphasized variability in study designs limits the strength of these conclusions.
August 2025 in “Ciencia Latina Revista Científica Multidisciplinar” This study identified various therapeutic applications of rosemary in humans, including cellular, dental, dermatological, metabolic, respiratory, and nervous system conditions, supporting its potential in evidence-based medicine.
February 2025 in “Revista Eletrônica Acervo Saúde” This integrative review found that triamcinolone hexacetonide remains the primary treatment for mild to moderate alopecia areata but noted its significant side effects with prolonged use, while emerging therapies like PRP and minoxidil offer promising alternative benefits with fewer risks.
August 2024 in “Journal of Dermatology for Physician Assistants” In this review, potential causes of COVID-19 and immunization-induced hair loss are explored, highlighting the need for early treatment and further research to clarify whether stress, viral infection, treatment medications, or nutritional deficiencies are responsible.
February 2024 in “Dermatologic Surgery” This review discusses the evidence for platelet-rich plasma in hair restoration and skin rejuvenation, highlighting its benefits but noting a lack of consensus on best practices and protocols.
December 2023 in “International Journal of Social health” This systematic review reports that PRP therapy on the scalp is effective in treating androgenic alopecia in men, with all reviewed studies highlighting its benefits and positive impacts.
August 2023 in “Vittalle” This integrative literature review investigated clinical trials on using medicinal plants, herbal products, and dietary supplements for treating alopecia, noting a need for further studies due to limited chemical-pharmaceutical analyses of the plant species involved, which include Allium sativum and Rosmarinus officinalis.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviewed literature on using the dermapem technique for treating female androgenetic alopecia and found that it effectively controls and stabilizes hair loss by enhancing nutrient supply and absorption in the scalp, with the technique considered safe.
April 2023 in “Research Society and Development” In this study, a literature review found that corticosteroids were effective and safe for treating Alopecia Areata by stimulating hair follicles and extending the anagen phase, based on data from 2010 to 2022.
January 2023 in “The Egyptian Journal of Hospital Medicine” This review discusses the potential of platelet-rich plasma as a new and promising treatment for striae distensa, noting its lack of associated risks like hyperpigmentation or infection, but reports no clinical results.
December 2022 in “International Journal of Health Science” This review discusses the pathophysiological impacts of hyperandrogenism in women with PCOS and reports no new clinical results; the authors highlight lifestyle changes as a primary management strategy.
June 2022 in “Research Square (Research Square)” This study revealed that metformin, beyond its hypoglycemic use, may have potential reuse in treating obesity, cardio-cerebrovascular diseases, and more, including possible future applications for Alzheimer's and other conditions.
November 2021 in “Research, Society and Development” This review covers different treatment options for alopecia areata and androgenetic alopecia and emphasizes individualized treatment plans, combining pharmacological therapy with psychological support; no new clinical results are reported.
This review reports the first known case of hair repigmentation associated with lamivudine use and examines mechanisms related to drug-induced hair repigmentation, suggesting potential therapeutic strategies for reversing hair graying.
March 2020 in “Revista Eletrônica da Faculdade de Ceres” This review discusses the role of latanoprost in hair growth but reports no clinical results; the authors suggest further research to determine its efficacy and optimal treatment regimen.
May 2015 in “Journal of The American Academy of Dermatology” This review discusses an algorithm using patient history, clinical examination, and tests to help diagnose hair loss in women, but it reports no new clinical results.
This article provides background information on hereditary hair loss and indicates it can begin in women as early as age 30, but presents no new results.
November 2022 in “Journal of Investigative Dermatology” This literature review indicates that combining PRP with minoxidil therapy may improve hair growth and patient satisfaction in androgenetic alopecia compared to monotherapies, though study limitations exist.
This study found that platelet-rich plasma therapy was more effective than minoxidil 5% for treating male-pattern baldness and also showed beneficial effects when combined with minoxidil.
December 2021 in “International Journal of Medicine in Developing Countries” This review examined existing studies on topical finasteride for androgenetic alopecia and noted inconsistent application of hair evaluation methods, suggesting a need for standardization in future research.
November 2021 in “Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo” This review of current research suggests that combining microneedling with minoxidil, and possibly platelet-rich plasma or mesotherapy, may achieve better hair growth results for androgenetic alopecia than conventional methods.
4 citations
,
December 2021 in “Vestnik dermatologii i venerologii” This review reported that various nonsurgical treatments, like cryosurgery, photodynamic therapy, and topical medications, offer effective alternatives for basal cell carcinoma management, especially when surgery is unsuitable, and treatment decisions should consider tumor characteristics and patient preferences.
2 citations
,
October 2022 in “International journal of Ayurvedic medicine” This review examines the traditional uses and biological activities of Glycyrrhiza glabra in Ayurveda, but reports no new clinical results; the authors identify a gap in evidence supporting its medicinal potential.
2 citations
,
November 2018 in “Destaques Acadêmicos” This review examines available aesthetic treatments for androgenetic alopecia, finding that microneedling shows the most promising results among the methods evaluated, including low-level laser therapy and mesotherapy.
1 citations
,
May 2024 in “Journal of Pharmacopolium” This review compares nanoemulsion formulas from several plants, such as argan and candlenut oils, which showed enhanced effectiveness in promoting hair growth in animal tests.
1 citations
,
May 2022 in “Recima21” This study reports that combining microneedling with low-intensity laser therapy appears to be a safe and effective treatment for androgenetic alopecia, as indicated by a literature review.